CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial The Science Underlying COVID-19: Implications for the Cardiovascular System Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study Feasibility and efficacy of the ultrashort side branch dedicated balloon in coronary bifurcation stenting Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

Original ResearchJuly 15, 2021

JOURNAL:PLoS One. Article Link

Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry

LB Daniels, JT Ren, K Kumar et al. Keywords: COVID-19; CVD patients; statin prevention; death

FULL TEXT PDF